India Inc registered a growth of 14 per cent in its net profit at Rs 3.37 lakh crore in the quarter ended December 2024, ...

Indian equity markets extended their downward trend for the eighth consecutive session on Friday, 14 February 2024, marking ...

Today, majors across segments including Parle Industries, Easy Trip Planners, Bajaj Consumer Care, Aditya Birla Fashion & ...

The Nifty Pharma Index has taken a hit, dropping nearly 2% in Friday’s trade. Over the last five days, the index has declined by approximately 4.3%, and on a year-to-date basis, it has fallen by ...

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

Over the years, India has been imposing tariffs on several imports in an attempt to protect Indian industry and give a push ...

Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...

Investor Summit has drawn US$115 billion in investments, alongside the launch of its Industrial Policy 2025-30.

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

With Asian stocks rising in early Friday trading and overnight Wall Street indices closing the day higher after the ...

India stock market capitalisation has dropped below the $4-trillion mark for the first time in more-than-14 months, bogged ...

Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies, has reported a standalone net profit of Rs. 20.77 crore for the Q3 FY25 ended December 2024 as against a net profit of Rs.